Showing 1-10 of 1,354 results
-
Bristol-Myers Squibb to buy Amylin for $7 bln
AFP, Published on 30/06/2012
» Pharmaceutical giant Bristol-Myers Squibb announced it will purchase diabetes drug maker Amylin Pharmaceuticals, Inc. for about $7 billion.
-
Drugmaker AstraZeneca announces 2,300 more job cuts
AFP, Published on 21/03/2013
» British pharmaceutical company AstraZeneca on Thursday said it was cutting 2,300 jobs on top of the 1,600 losses it announced at the start of the week, in a major restructuring of the group over the next three years.
-
Ranbaxy taking 'stringent steps' to end US FDA ban
AFP, Published on 21/09/2013
» India's biggest drugmaker by sales, Ranbaxy Laboratories, has assured shareholders it is taking "stringent steps" to resolve a US ban on imports of medicines made at its newly renovated showcase plant.
-
AstraZeneca takes control of diabetes venture for $4.1bn
AFP, Published on 19/12/2013
» Anglo-Swedish drugs firm AstraZeneca said Thursday it will buy Bristol-Myers Squibb's stake in their diabetes venture for up to $4.1 billion (3.0 billion euros).
-
Images search for " astrazeneca "
-
Deal fever hits global pharma sector
AFP, Published on 27/04/2014
» Global pharmaceutical companies facing major patent expirations have announced billions of dollars of transactions in a wave of deal-making that could ultimately include mega-mergers and hostile takeovers.
-
Drug giants lock horns over $100 bn merger bid
AFP, Published on 28/04/2014
» US drug titan Pfizer Monday said it wants to acquire AstraZeneca in a deal potentially worth $100 billion to fortify its pipeline of new medicines and sharply cut its tax bill.
-
AstraZeneca snubs Pfizer's improved $106 bn takeover
AFP, Published on 02/05/2014
» British drugs giant AstraZeneca on Friday rejected a sweetened $106-billion takeover bid from US rival Pfizer, hitting out at the "inadequate" offer as it battles to remain independent.
-
Pfizer hints at hostile bid for AstraZeneca
AFP, Published on 05/05/2014
» Pfizer said Monday that it remains keen to acquire AstraZeneca but hinted at a hostile takeover campaign if the British company continues to rebuff its offer.
-
Pfizer under growing political pressure in US, Britain
AFP, Published on 10/05/2014
» Pfizer faces growing political pressure at home and in Britain as speculation mounts on whether the US pharmaceutical giant will sweeten its buyout offer for British company AstraZeneca.
-
Job losses possible in AstraZeneca tie-up, Pfizer chief admits
AFP, Published on 13/05/2014
» The head of US drugs giant Pfizer admitted Tuesday that jobs could be lost if it succeeds in taking over British competitor AstraZeneca in a pound sterling63-billion deal ($106 billion, 77 billion euros).
Your recent history
-
Recently searched
-
Recently viewed links